financetom
Business
financetom
/
Business
/
Matthews International Announces Win in Arbitration Versus Tesla in Battery Technology Case
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Matthews International Announces Win in Arbitration Versus Tesla in Battery Technology Case
Feb 6, 2025 7:57 AM

10:30 AM EST, 02/06/2025 (MT Newswires) -- Matthews International ( MATW ) said Thursday an arbitrator ruled in its favor in a dispute with Tesla (TSLA), affirming Matthews' right to sell its dry battery electrode technology to other customers.

The company filed for arbitration in January 2024 after a dispute with Tesla and said Tesla later pursued a separate legal action in federal court.

Matthews said it will resume sales immediately to other customers in the electric vehicle industry.

Tesla didn't immediately respond to a request for comment from a MT Newswires.

Shares of Matthews rose 7.4% in recent Thursday trading, and Tesla fell 2.8%.

Price: 28.72, Change: +1.98, Percent Change: +7.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kraft-Heinz pulls key Lunchables meals from U.S. free- and low-cost school lunch program
Kraft-Heinz pulls key Lunchables meals from U.S. free- and low-cost school lunch program
Nov 12, 2024
NEW YORK (Reuters) - Kraft Heinz is no longer making its packaged lunch brand Lunchables for low-income students receiving free and reduced-priced meals from a federal program, according to a company statement, the latest blow to one of the company's most iconic products. Chicago-based Kraft Heinz announced plans to sell to the school lunch program early last year at an...
ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised
ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised
Nov 12, 2024
05:15 PM EST, 11/12/2024 (MT Newswires) -- ICU Medical ( ICUI ) reported Q3 adjusted earnings late Tuesday of $1.59 per diluted share, up from $1.57 a year earlier. Analysts polled by Capital IQ expected $1.25. Revenue for the quarter ended Sept. 30 was $589.1 million, up from $553.3 million a year earlier. Analysts surveyed by Capital IQ expected $576.7...
Resmed Insider Sold Shares Worth $3,615,821, According to a Recent SEC Filing
Resmed Insider Sold Shares Worth $3,615,821, According to a Recent SEC Filing
Nov 12, 2024
05:41 PM EST, 11/12/2024 (MT Newswires) -- Michael J. Farrell, Chief Executive Officer, on November 07, 2024, sold 14,683 shares in Resmed ( RMD ) for $3,615,821. Following the Form 4 filing with the SEC, Farrell has control over a total of 468,344 shares of the company, with 464,254 shares held directly and 4,090 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/xslF345X05/form4.xml ...
Exclusive-Pfizer explores sale of hospital drugs unit, sources say
Exclusive-Pfizer explores sale of hospital drugs unit, sources say
Nov 12, 2024
NEW YORK (Reuters) - Pfizer ( PFE ) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter. The unit, now called Pfizer Hospital, was formed after Pfizer ( PFE ) bought Hospira for about...
Copyright 2023-2026 - www.financetom.com All Rights Reserved